Skip to content

ARVN

Arvinas, Inc.

NASDAQ · Healthcare · Biotechnology · US

$9.39
+0.86%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue316.7M262.6M263.4M78.5M131.4M
Cost of Revenue11.3M5.2M
Gross Profit305.4M257.4M263.4M78.5M131.4M
Operating Expenses
R&D Expense238.4M282.9M348.2M379.7M315.0M
SG&A Expense85.2M89.4M165.4M100.3M79.6M
General & Admin Expense87.1M89.4M165.4M100.3M79.6M
Selling & Marketing Expense(1.9M)
Other Expenses(4.1M)
Total Operating Expenses319.5M372.3M513.6M480.0M394.6M
Cost and Expenses330.8M377.5M513.6M480.0M394.6M
Operating Income (EBIT)(14.1M)(114.9M)(250.2M)(401.5M)(263.2M)
Non-Operating
Interest Income29.9M22.0M54.8M38.8M12.0M
Interest Expense
Net Interest Income29.9M22.0M54.8M38.8M12.0M
Other Non-Op Income/Expense24.2M34.4M51.9M35.1M1.6M
Non-Operating Income (excl Interest)(13.2M)(34.4M)(51.9M)(35.1M)(1.6M)
EBT (Pre-Tax Income)10.1M(80.5M)(198.3M)(366.4M)(261.6M)
Income Tax Expense800.0K300.0K600.0K900.0K20.9M
Bottom Line
Net Income9.3M(80.8M)(198.9M)(367.3M)(282.5M)
Earnings from Cont. Ops9.3M(80.8M)(198.9M)(367.3M)(282.5M)
Earnings from Discont. Ops
Bottom Line Net Income9.3M(80.8M)(198.9M)(367.3M)(282.5M)
Per Share
Basic EPS$0.19($1.28)($2.77)($6.62)($5.31)
Diluted EPS$0.16($1.28)($2.77)($6.62)($5.31)
Revenue Per Share$4.89$4.05$3.66$1.41$2.47
Shares
Basic Shares Outstanding64.8M64.9M71.9M55.5M53.2M
Diluted Shares Outstanding65.7M64.9M71.9M55.5M53.2M
Profitability Metrics
EBITDA2.9M(75.3M)(191.7M)(359.7M)(253.4M)
D&A3.8M5.2M6.6M6.7M8.2M
EBIT(900.0K)(80.5M)(198.3M)(366.4M)(261.6M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026